Plasmacytoma
📧 Sign up to get email alerts when something new happens for Plasmacytoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Engineered Dendritic Cell Vaccines for Multiple Myeloma [Phase 1]
Phase 1 clinical trial evaluating an engineered dendritic cell vaccine for multiple myeloma; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a frontline combination CAR-T cell therapy for multiple myeloma or plasmacytoma is currently recruitin…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma [Phase 1]
Phase 1 trial evaluating adding KRT-232 (AMG 232) to standard chemotherapy in relapsed multiple myeloma, with plasmacytoma also listed; the …
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma [Phase 2]
Phase 2 clinical trial assessing lenalidomide and CC-486 with radiation therapy in patients with plasmacytoma; the study is currently active…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating a conditioning regimen with panobinostat, gemcitabine hydrochloride, busulfan, and melphalan before stem cell tra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome [EARLY_Phase 1]
Clinical trial update on an early-phase 1 study of ixazomib citrate, lenalidomide, and dexamethasone for POEMS syndrome (plasmacytoma) that …
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: T-cell Receptor α/β Depleted Donor Lymphocyte Infusion [Phase 1]
Phase 1 trial of T-cell receptor α/β-depleted donor lymphocyte infusion was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer [Phase 1]
Phase 1 clinical trial evaluating the combination of sodium selenite with radiation therapy in patients with metastatic cancer.
-
CLINICAL_TRIALS trial_result · 2022-12-23Clinical Trial Update: Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma [Phase 3]
Phase 3 trial investigating an immunomodulatory therapy for high-risk solitary bone plasmacytoma is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma [Phase 2]
Phase 2 trial evaluating daratumumab in combination with DCEP for relapsed multiple myeloma with plasmacytoma.
-
CLINICAL_TRIALS research · 2017-04-24Clinical Trial Update: S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma [Phase 2]
Phase 2 clinical trial S0340 evaluating MRI and FDG PET for diagnosing solitary plasmacytoma was terminated, per SWOG Cancer Research Networ…
-
CLINICAL_TRIALS research · 2016-10-07Clinical Trial Update: S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
This clinical trial update describes the S0120 study that collects blood and bone marrow samples from patients with monoclonal gammopathy of…
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma [Phase 1]
This ClinicalTrials.gov record reports a completed Phase 1 trial evaluating a dendritic cell-based idiotype vaccination in Stage I multiple …